Evidence map›Paper›PMID 38621441›Full record

ArticleJournal of cardiac failure2025

Association of Psychosocial Risk Factors With Quality of Life and Readmissions 1 Year After LVAD Implantation.

Jeffrey Wang, Alexis K Okoh, Yuxuan Chen, Rebecca S Steinberg, Apoorva Gangavelli, Krishan J Patel, Yi-An Ko, Jeffrey D Alexis, Shivani A Patel, David J Vega and 4 more

Abstract read
In one paragraph

Article in Journal of cardiac failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jeffrey WangEmory University School of Medicine, Division of Cardiology, Atlanta, GA.
Alexis K OkohEmory University School of Medicine, Division of Cardiology, Atlanta, GA.
Yuxuan ChenEmory University Rollins School of Public Health, Department of Biostatistics and Bioinformatics, Atlanta, GA.
Rebecca S SteinbergEmory University School of Medicine, Division of Cardiology, Atlanta, GA.
Apoorva GangavelliEmory University School of Medicine, Division of Cardiology, Atlanta, GA.
Krishan J PatelEmory University School of Medicine, Division of Cardiology, Atlanta, GA.
Yi-An KoEmory University Rollins School of Public Health, Department of Biostatistics and Bioinformatics, Atlanta, GA.
Jeffrey D AlexisUniversity of Rochester Medical Center, Division of Cardiology, Rochester, NY.
Shivani A PatelEmory University Rollins School of Public Health, Hubert Department of Global Health, Atlanta, GA.
David J VegaEmory University School of Medicine, Department of Surgery, Atlanta, GA.
Mani DaneshmandEmory University School of Medicine, Department of Surgery, Atlanta, GA.
Ersilia M DefilippisCenter for Advanced Cardiac Care, Columbia University Irving Medical Center, Division of Cardiology, New York, NY.
Khadijah BreathettIndiana University School of Medicine, Division of Cardiology, Indianapolis, IN.
Alanna A MorrisEmory University School of Medicine, Division of Cardiology, Atlanta, GA. Electronic address: aamorr3@emory.edu.

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
Research Trainng in Academic CardiologyT32HL007745 · NHLBI · EMORY UNIVERSITY · PI TAYLOR, WILLIAM ROBERT · 1994 to 2023
$10.6M
J: NRSA Training CoreTL1TR002382 · NCATS · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Vasiliki Michopoulos · 2017 to 2026
$8.5M
Reducing Ethnic-racial Disparities in Cardiac Arrest Survival Outcomes (RED-CASO)R01HL160734 · NHLBI · SAINT LUKE'S HOSPITAL · PI CHAN, PAUL SHEUNG-YAN, GIROTRA, SAKET · 2022 to 2025
$2.6M
Seeking Objectivity in Allocation of Advanced Heart Failure (SOCIAL HF) Therapies TrialR01HL159216 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI BREATHETT, KHADIJAH · 2022 to 2025
$2.6M
Addressing Individual Provider Bias and Group Decision-Making in Selection of Advanced Heart Failure Therapies in Racial/Ethnic MinoritiesK01HL142848 · NHLBI · UNIVERSITY OF ARIZONA · PI BREATHETT, KHADIJAH · 2018 to 2021
$858k
AHRQ HHS R01 HS026081NCATS NIH HHS TL1 TR002382NCATS NIH HHS UL1 TR002378NHLBI NIH HHS K01 HL142848NHLBI NIH HHS R01 HL159216NHLBI NIH HHS R01 HL160734NHLBI NIH HHS T32 HL007745
6 · The paper itself

Abstract

backgroundAmong patients with advanced heart failure (HF), treatment with a left ventricular assist device (LVAD) improves health-related quality of life (HRQOL). We investigated the association between psychosocial risk factors, HRQOL and outcomes after LVAD implantation.

methodsA retrospective cohort (n = 9832) of adults aged ≥ 19 years who received durable LVADs between 2008 and 2017 was identified by using the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). Patients were considered to have psychosocial risk factors if ≥ 1 of the following were present: (1) substance abuse; (2) limited social support; (3) limited cognitive understanding; (4) repeated nonadherence; and (5) major psychiatric disease. Multivariable logistic and linear regression models were used to evaluate the association between psychosocial risk factors and change in Kansas City Cardiomyopathy Questionnaire (KCCQ)-12 scores from baseline to 1 year, persistently poor HRQOL (KCCQ-12 score < 45 at baseline and 1 year), and 1-year rehospitalization.

resultsAmong the final analytic cohort, 2024 (20.6%) patients had ≥ 1 psychosocial risk factors. Psychosocial risk factors were associated with a smaller improvement in KCCQ-12 scores from baseline to 1 year (mean ± SD, 29.1 ± 25.9 vs 32.6 ± 26.1; P = 0.015) for a difference of -3.51 (95% confidence interval [CI]: -5.88 to -1.13). Psychosocial risk factors were associated with persistently poor HRQOL (adjusted odds ratio [aOR] 1.35, 95% confidence interval [CI] 1.04-1.74), and 1-year all-cause readmission (adjusted hazard ratio [aHR] 1.11, 95% CI 1.05-1.18). Limited social support, major psychiatric disorder and repeated nonadherence were associated with persistently poor HRQOL, while major psychiatric disorder was associated with 1-year rehospitalization.

conclusionThe presence of psychosocial risk factors is associated with lower KCCQ-12 scores and higher risk for readmission at 1 year after LVAD implantation. These associations are statistically significant, but further research is needed to determine whether these differences are clinically meaningful.

Indexed as

Heart-Assist DevicesHeart FailurePatient ReadmissionQuality of LifeAdultAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedRegistriesRetrospective StudiesRisk FactorsSocial SupportTime Factors

Identifiers

PMID38621441
PMCPMC11889494

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.